Immunotherapeutic efficacy of recombinant canine IL-15 as an adjunct to chemotherapy in canine lymphoma

IntroductionCanine lymphoma is a common hematopoietic malignancy with variable response to standard chemotherapy. Interleukin-15 (IL-15) is known to enhance cytotoxic lymphocyte activity, and this study aimed to evaluate the efficacy and safety of a recombinant canine IL-15 (rcIL-15) as an adjunct t...

Full description

Bibliographic Details

Published in:	Frontiers in Veterinary Science
Main Authors:	Min-Hee Kang, Jaeil Lee, Sang-Ki Kim, Kyeyoung Koh, Mi-Ae Kang, Hee-Myung Park
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	tumor biomarkers canine lymphoma recombinant canine interleukin-15 immunotherapy quality of life
Online Access:	https://www.frontiersin.org/articles/10.3389/fvets.2025.1596084/full